PATENT CLAIM ANALYSIS

Application Number: 15773367
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "254020"]

Abstract:
MyD88 inhibitor can be used to prevent, for example, post myocardial infarction ischemia reperfusion injury, post severed limb replantation ischemia reperfusion injury and post transplantation ischemia reperfusion injury, and to play important role in production of organ preservation solution, cell preservation solution etc. Furthermore, results of in vitro experiment show that MyD88 inhibitor TJM2010-5 can effectively reduce the level of inflammatory factors in graft through inhibiting the pathway, which means that it is closely related to the generation of inflammatory factors, therefore, the TJM2010-5 can become the effective method for treating of various inflammations, prevent the vicious circle and vicious transformation of chronic inflammation, and prevent and treat inflammatory cancerization etc.

Claim (Index 9):
A method for treating ischemia reperfusion injury, comprising administering an effective amount of TJM2010-5 of formula: to a human or animal in need thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.74648
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14016126', '13370079', '13518513', '14401524', '14759452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6639221018296277
- 35 USC 102 Novelty (BERT): 0.5136978675206129
- Combined Prediction Score: 0.6488996783987263
- Mean Citation Score: 220.278252
- Max Citation Score: 255.57442000000003
- Similarity Product: 173.82718287547593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test